---
title: "Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296645903.md"
description: "Jefferies analyst Matthew Taylor reiterated a Buy rating on Abbott Laboratories (ABT) with a $135 price target. Taylor, a 4-star analyst covering healthcare, has a 7.6% average return. The stock currently holds a Strong Buy consensus among analysts, with an average price target of $123.21."
datetime: "2026-08-21T16:25:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296645903.md)
  - [en](https://longbridge.com/en/news/296645903.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296645903.md)
generator: "portal-rs"
---

# Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)

In a report released today, Matthew Taylor from Jefferies reiterated a Buy rating on Abbott Laboratories, with a price target of $135.00.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Taylor is a 4-star analyst with an average return of 7.6% and a 56.14% success rate. Taylor covers the Healthcare sector, focusing on stocks such as Boston Scientific, GE Healthcare Technologies Inc, and Abbott Laboratories.

Abbott Laboratories has an analyst consensus of Strong Buy, with a price target consensus of $123.21.

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [GEHC.US](https://longbridge.com/en/quote/GEHC.US.md)

## Related News & Research

- [Xcel Wealth Management LLC Cuts Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/296700328.md)
- [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md)
- [Murphy Pohlad Asset Management LLC Purchases 12,140 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296461096.md)
- [Abbott Laboratories $ABT Holdings Increased by Merit Financial Group LLC](https://longbridge.com/en/news/296328656.md)
- [D.A. Davidson & CO. Sells 38,578 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296694848.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**